Culture media from hypoxia conditioned endothelial cells protect human intestinal cells from hypoxia/reoxygenation injury

Experimental Cell Research

Volumn 322, Issue 1, 2014, Pages 62-70

  Hummitzsch, Lars ^a   Zitta, Karina ^a   Bein, Berthold ^a   Steinfath, Markus ^a   Albrecht, Martin ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Endothelial cells; Hypoxia; Intestinal ischemia; Ischemia reperfusion injury; Remote ischemic preconditioning

Indexed keywords

CASPASE 3; CASPASE 7; GELATINASE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STAT5 PROTEIN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL HYPOXIA; CELL STRUCTURE; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTESTINE CELL; INTRACELLULAR SIGNALING; ISCHEMIC PRECONDITIONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECRETION; REOXYGENATION; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL;

ENDOTHELIAL CELLS; HYPOXIA; INTESTINAL ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; REMOTE ISCHEMIC PRECONDITIONING;

CACO-2 CELLS; CELL HYPOXIA; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOPROTECTION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; INTESTINAL DISEASES; INTESTINES; ISCHEMIC PRECONDITIONING; PHOSPHORYLATION; REPERFUSION INJURY;

EID: 84893775476     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.12.022     Document Type: Article

References (58)

1. Oxman T., Arad M., Klein R., Avazov N., Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am. J. Physiol. 1997, 273:H1707-H1712.
2. Hausenloy D.J., Mwamure P.K., Venugopal V., Harris J., Barnard M., Grundy E., Ashley E., Vichare S., Di Salvo C., Kolvekar S., Hayward M., Keogh B., MacAllister R.J., Yellon D.M. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007, 370:575-579.
3. Konstantinov I.E., Li J., Cheung M.M., Shimizu M., Stokoe J., Kharbanda R.K., Redington A.N. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 2005, 79:1691-1695.
4. Lai I.R., Chang K.J., Chen C.F., Tsai H.W. Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. Transplantation 2006, 81:1311-1317.
5. Harkin D.W., Barros D'Sa A.A., McCallion K., Hoper M., Campbell F.C. Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J. Vasc. Surg. 2002, 35:1264-1273.
6. Hu S., Dong H., Zhang H., Wang S., Hou L., Chen S., Zhang J., Xiong L. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res. 2012, 1459:81-90.
7. Jensen H.A., Loukogeorgakis S., Yannopoulos F., Rimpilainen E., Petzold A., Tuominen H., Lepola P., Macallister R.J., Deanfield J.E., Makela T., Alestalo K., Kiviluoma K., Anttila V., Tsang V., Juvonen T. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 2011, 123:714-721.
8. Wever K.E., Warle M.C., Wagener F.A., van der Hoorn J.W., Masereeuw R., van der Vliet J.A., Rongen G.A. Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine. Nephrol. Dial. Transpl. 2011, 26:3108-3117. (Official Publication of the European Dialysis and Transplant Association-European Renal Association).
9. Saeki I., Matsuura T., Hayashida M., Taguchi T. Ischemic preconditioning and remote ischemic preconditioning have protective effect against cold ischemia-reperfusion injury of rat small intestine. Pediatr. Surg. Int. 2011, 27:857-862.
10. Ozden N., Gurses B. Mesenteric ischemia in the elderly. Clin. Geriatr. Med. 2007, 23:871-887. (vii-viii).
11. Korth U., Krieter H., Denz C., Janke C., Ellinger K., Bertsch T., Henn C., Klein J. Intestinal ischaemia during cardiac arrest and resuscitation: comparative analysis of extracellular metabolites by microdialysis. Resuscitation 2003, 58:209-217.
12. Rupani B., Caputo F.J., Watkins A.C., Vega D., Magnotti L.J., Lu Q., Xu da Z., Deitch E.A. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 2007, 141:481-489.
13. Stefaniak J., Baron D.M., Metnitz P.G., Kramer L. Disturbances of gastrointestinal motility in intensive care units. Anasthesiol. Intensivmed. Natfallmed. Schmerzther.: Anaesthesiol. Intensivmed. Notfallmed. Schmerzther. 2010, 45:696-706.
14. Roumen R.M., van der Vliet J.A., Wevers R.A., Goris R.J. Intestinal permeability is increased after major vascular surgery. J. Vasc. Surg. 1993, 17:734-737.
15. Chaudhuri N., James J., Sheikh A., Grayson A.D., Fabri B.M. Intestinal ischaemia following cardiac surgery: a multivariate risk model. Eur. J. Cardiothorac. Surg. 2006, 29:971-977. (Journal of the European Association for Cardio-thoracic Surgery).
16. Solligard E., Juel I.S., Spigset O., Romundstad P., Gronbech J.E., Aadahl P. Gut luminal lactate measured by microdialysis mirrors permeability of the intestinal mucosa after ischemia. Shock 2008, 29:245-251.
17. Sun Z., Lasson A., Olanders K., Deng X., Andersson R. Gut barrier permeability, reticuloendothelial system function and protease inhibitor levels following intestinal ischaemia and reperfusion-effects of pretreatment with N-acetyl-l-cysteine and indomethacin. Dig. Liver Dis. 2002, 34:560-569. (Journal of The Italian Society of Gastroenterology and the Italian Association for the Study of the Liver).
18. Swank G.M., Deitch E.A. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J. Surg. 1996, 20:411-417.
19. Doig C.J., Sutherland L.R., Sandham J.D., Fick G.H., Verhoef M., Meddings J.B. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 1998, 158:444-451.
20. Pell T.J., Baxter G.F., Yellon D.M., Drew G.M. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am. J. Physiol. 1998, 275:H1542-H1547.
21. Patel H.H., Moore J., Hsu A.K., Gross G.J. Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J. Mol. Cell. Cardiol. 2002, 34:1317-1323.
22. Schoemaker R.G., van Heijningen C.L. Bradykinin mediates cardiac preconditioning at a distance,. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1571-H1576.
23. Wolfrum S., Nienstedt J., Heidbreder M., Schneider K., Dominiak P., Dendorfer A. Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul. Pept. 2005, 127:217-224.
24. Di Filippo C., Rossi F., Rossi S., D'Amico M. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J. Leukocyte Biol. 2004, 75:453-459.
25. Zitta K., Meybohm P., Bein B., Heinrich C., Renner J., Cremer J., Steinfath M., Scholz J., Albrecht M. Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: Involvement of Matrixmetalloproteinase-2 and -9. Mol. Med. 2012, 18:29-37.
26. Zitta K., Meybohm P., Bein B., Rodde C., Steinfath M., Scholz J., Albrecht M. Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in-vitro: application of an enzyme based oxygen deficiency system. Eur. J. Pharmacol. 2010, 628:11-18.
27. Zitta K., Meybohm P., Bein B., Ohnesorge H., Steinfath M., Scholz J., Albrecht M. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur. J. Pharmacol. 2010, 645:39-46.
28. Meybohm P., Gruenewald M., Albrecht M., Zacharowski K.D., Lucius R., Zitta K., Koch A., Tran N., Scholz J., Bein B. Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 2009, 4:e7588.
29. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc. Res. 2004, 61:448-460.
30. Alvarez-Tejado M., Naranjo-Suarez S., Jimenez C., Carrera A.C., Landazuri M.O., del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 2001, 276:22368-22374.
31. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol. Ther. 2008, 120:172-185.
32. Kharbanda R.K., Nielsen T.T., Redington A.N. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009, 374:1557-1565.
33. Kloner R.A. Clinical application of remote ischemic preconditioning. Circulation 2009, 119:776-778.
34. N. Selzner, M. Boehnert, M. Selzner, Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications, Transplant. Rev. (Orlando) 26 (2012) 115-124.
35. Mallick I.H., Yang W., Winslet M.C., Seifalian A.M. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig. Dis. Sci. 2004, 49:1359-1377.
36. Li C., Li Y.S., Xu M., Wen S.H., Yao X., Wu Y., Huang C.Y., Huang W.Q., Liu K.X. Limb remote ischemic preconditioning for intestinal and pulmonary protection during elective open infrarenal abdominal aortic aneurysm repair: a randomized controlled trial. Anesthesiology 2013, 118:842-852.
37. Lim S.Y., Hausenloy D.J. Remote ischemic conditioning: from bench to bedside. Front. Physiol. 2012, 3:27.
38. Hausenloy D.J., Yellon D.M. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc. Res. 2008, 79:377-386.
39. B. Bein, P. Meybohm, [Organ Protection by Conditioning], Anasthesiol. Intensivmed. Natfallmed. Schmerzther.: Anaesthesiol. Intensivmed. Notfallmed. Schmerzther. 45 (2010) 254-261; quiz 262.
40. Hampson N.B., Piantadosi C.A. Near infrared monitoring of human skeletal muscle oxygenation during forearm ischemia. J. Appl. Physiol. 1988, 64:2449-2457.
41. 2 imaging during tourniquet-induced forearm ischemia using planar optical oxygen sensors. Skin Res. Technol. 2008, 14:304-311.
42. Allen C.B., Schneider B.K., White C.W. Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L1021-L1027.
43. Baumann R.P., Penketh P.G., Seow H.A., Shyam K., Sartorelli A.C. Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells. Radiat. Res. 2008, 170:651-660.
44. Mueller S., Millonig G., Waite G.N. The GOX/CAT system: a novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture. Adv. Med. Sci. 2009, 54:121-135.
45. Zitta K., Meybohm P., Bein B., Ohnesorge H., Steinfath M., Scholz J., Albrecht M. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur. J. Pharmacol. 2010, 645:39-46.
46. Zitta K., Meybohm P., Bein B., Rodde C., Steinfath M., Scholz J., Albrecht M. Hypoxia-induced cell damage is reduced by mild hypothermia and postconditioning with catalase in-vitro: application of an enzyme based oxygen deficiency system. Eur. J. Pharmacol. 2010, 628:11-18.
47. Tse D., Stan R.V. Morphological heterogeneity of endothelium. Semin. Thromb. Hemost. 2010, 36:236-245.
48. Gori T., Lisi M., Forconi S. Ischemia and reperfusion: the endothelial perspective. A radical view. Clin. Hemorheol. Micro. 2006, 35:31-34.
49. Jabs A., Fasola F., Muxel S., Munzel T., Gori T. Ischemic and non-ischemic preconditioning: endothelium-focused translation into clinical practice. Clin. Hemorheol. Micro. 2010, 45:185-191.
50. Gourdin M.J., Bree B., De Kock M. The impact of ischaemia-reperfusion on the blood vessel. Eur. J. Anaesthesiol. 2009, 26:537-547.
51. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell. Biol. 2007, 8:221-233.
52. V. Vargova, M. Pytliak, V. Mechirova, Matrix Metalloproteinases, Exs 103 (2012) 1-33.
53. Malla N., Sjoli S., Winberg J.O., Hadler-Olsen E., Uhlin-Hansen L. Biological and pathobiological functions of gelatinase dimers and complexes. Connect. Tissue Res. 2008, 49:180-184.
54. Grace P.A. Ischaemia-reperfusion injury. Br. J. Surg. 1994, 81:637-647.
55. Jean-St-Michel E., Manlhiot C., Li J., Tropak M., Michelsen M.M., Schmidt M.R., McCrindle B.W., Wells G.D., Redington A.N. Remote preconditioning improves maximal performance in highly trained athletes. Med. Sci. Sports Exerc. 2011, 43:1280-1286.
56. Shimizu M., Tropak M., Diaz R.J., Suto F., Surendra H., Kuzmin E., Li J., Gross G., Wilson G.J., Callahan J., Redington A.N. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin. Sci. (Lond) 2009, 117:191-200.
57. Serejo F.C., Rodrigues L.F., da Silva Tavares K.C., de Carvalho A.C., Nascimento J.H. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J. Cardiovasc. Pharmacol. 2007, 49:214-220.
58. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 2000, 256:34-41.